The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Application of quality by design in the current drug development
Open accessAbstract
Quality by Test was the only way to guarantee quality of drug products before FDA launched current Good Manufacturing Practice. To clearly understand the manufacture processes, FDA generalized Quality by Design (QbD) in the field of pharmacy, which is based on the thorough understanding of how materials and process parameters affect the quality profile of final products. The application of QbD in drug formulation and process design is based on a good understanding of the sources of variability and the manufacture process. In this paper, the basic knowledge of QbD, the elements of QbD, steps and tools for QbD implementation in pharmaceutics field, including risk assessment, design of experiment, and process analytical technology (PAT), are introduced briefly. Moreover, the concrete applications of QbD in various pharmaceutical related unit operations are summarized and presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Beer, T., Burggraeve, A., Fonteyne, M., Saerens, L., Remon, J. P., & Vervaet, C. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.12.012 · Cited by 559
Cited by
Design of experiments (DoE) in pharmaceutical development
N. Politis, S., Colombo, P., Colombo, G., & M. Rekkas, D. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1291672 · Cited by 597
Design of Experiments (DoE) applied to Pharmaceutical and Analytical Quality by Design (QbD)
Fukuda, I. M., Pinto, C. F. F., Moreira, C. D. S., Saviano, A. M., & Lourenço, F. R. (2018) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902018000001006 · Cited by 415
Current approaches of nanomedicines in the market and various stage of clinical translation
Shan, X., Gong, X., Li, J., Wen, J., Li, Y., & Zhang, Z. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.025 · Cited by 335
Non-Ionic Surfactants for Stabilization of Polymeric Nanoparticles for Biomedical Uses
Cortés, H., Hernández-Parra, H., Bernal-Chávez, S. A., Prado-Audelo, M. L. D., Caballero-Florán, I. H., Borbolla-Jiménez, F. V., González-Torres, M., Magaña, J. J., & Leyva-Gómez, G. (2021) · Materials · doi:10.3390/ma14123197 · Cited by 302
Giovannelli, L., Bari, E., Jommi, C., Tartara, F., Armocida, D., Garbossa, D., Cofano, F., Torre, M. L., & Segale, L. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.06.013 · Cited by 102
Metadata
- Authors
- Zhang, L., & Mao, S.
- Venue
- Asian Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 12
- Issue
- 1
- Pages
- 1-8
- ISSN
- 1818-0876 (ISSN-L)
- OpenAlex
- W2505448267
- Cited by
- 246
- References
- 1
- FWCI
- 10.23
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Application of quality by design in the current drug development. https://app.cochat.ai/papers/10.1016/j.ajps.2016.07.006
- The paper
- Zhang, L., & Mao, S. (2017). Application of quality by design in the current drug development. Asian Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.ajps.2016.07.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.